Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry

BACKGROUND: Azilsartan medoxomil (AZL-M), has been demonstrated to be more effective than the other sartans currently in use; however, there is insufficient information available comparing it with ACE-inhibitors. Therefore, we aimed to compare the efficacy, safety, and tolerability of AZL-M with tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Gitt, Anselm K., Bramlage, Peter, Potthoff, Sebastian A., Baumgart, Peter, Mahfoud, Felix, Buhck, Hartmut, Ehmen, Martina, Ouarrak, Taoufik, Senges, Jochen, Schmieder, Roland E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784379/
https://www.ncbi.nlm.nih.gov/pubmed/26956148
http://dx.doi.org/10.1186/s12872-016-0222-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784379/
https://www.ncbi.nlm.nih.gov/pubmed/26956148
http://dx.doi.org/10.1186/s12872-016-0222-6

Ejemplares similares